Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Oct 24, 2024
Thursday Oct 24, 2024
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading experts discuss best practice in the management of agitation in Alzheimer’s dementia and the potential of new pharmacological approaches that target aspects of the underlying pathophysiology.
The experts
- Prof. Jeffrey Cummings, University of Nevada, Las Vegas, NV, USA
- Prof. Krista Lanctôt, University of Toronto, ON, Canada
- Prof. James Galvin, University of Miami, FL, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
For further information visit:
https://touchneurologyime.org/cme/curriculums/agitation-in-alzheimers-dementia/
Thursday Oct 24, 2024
Thursday Oct 24, 2024
touchIN CONVERSATION for touchCARDIO
Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment landscape.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
The experts
- Prof. Manreet Kanwar, Allegheny General Hospital, Pittsburgh, PA, USA
- Prof. Jean-Luc Vachiéry, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium
For further information visit our website:
www.touchCARDIO.com
Thursday Oct 24, 2024
Thursday Oct 24, 2024
touchIN CONVERSATION for touchRESPIRATORY
Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment landscape.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
The experts
- Prof. Manreet Kanwar, Allegheny General Hospital, Pittsburgh, PA, USA
- Prof. Jean-Luc Vachiéry, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium
For further information visit our website:
www.touchRESPIRATORY.com
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchONCOLOGY.com
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchONCOLOGY.com
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchRESPIRATORY.com
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchRESPIRATORY.com
Tuesday Oct 15, 2024
Tuesday Oct 15, 2024
touchFOCUS for touchONCOLOGY
Listen to Dr Jennifer Carlisle, an expert in lung cancer, as she answers a series of questions on the targeted perioperative treatment strategies and best practices for patients with resectable and unresectable early-stage EGFR-mutant NSCLC. She also discusses how the evolving treatment landscape impacts biomarker testing and the importance of multidisciplinary care for optimizing outcomes in these patients.
The expert
Dr Jennifer Carlisle, Winship Cancer Institute of Emory University, Atlanta, GA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.org/EGFR-mutant-treatment-options-early-NSCLC
Monday Oct 07, 2024
Monday Oct 07, 2024
touchCONGRESS for touchONCOLOGY
Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mateos,
- Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below
Clinical themes
- Approved indications for BCMA-targeting agents,
- New approaches to the use of existing BCMA-targeting agents,
- Emerging BCMA-targeting agents
The internationally renowned multiple myeloma expert faculty
- Prof. María-Victoria Mateos: Salamanca, Spain,
- Dr Rakesh Popat: London, UK,
- Prof. Evangelos Terpos: Athens, Greece
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/bcma-mm-comy-eha-2024
Monday Oct 07, 2024
Monday Oct 07, 2024
touchCONGRESS for touchHAEMATOLOGY
Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mateos,
- Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below
Clinical themes
- Approved indications for BCMA-targeting agents,
- New approaches to the use of existing BCMA-targeting agents,
- Emerging BCMA-targeting agents
The internationally renowned multiple myeloma expert faculty
- Prof. María-Victoria Mateos: Salamanca, Spain,
- Dr Rakesh Popat: London, UK,
- Prof. Evangelos Terpos: Athens, Greece
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/bcma-mm-comy-eha-2024